Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson’s Disease – Business Wire (press release)
|
Synpromics Announces Collaboration with UCL to Develop Revolutionary Gene Therapy for Parkinson's Disease
Business Wire (press release) EDINBURGH, Scotland–(BUSINESS WIRE)–Synpromics Ltd is pleased to announce a new collaboration with UCL to generate a range of synthetic gene promoters for the central nervous system (CNS), to develop a gene therapy for Parkinson's disease. |
